Skip to main content

Table 3 Prevalence of HR and the association between HR and SUA

From: Serum uric acid concentration is associated with hypertensive retinopathy in hypertensive chinese adults

  

Prevalence of HR (%)

    

Serum Uric Acid (mg/dl)

N

Total

Males

Females

Model 1

Model 2

     

OR, 95% CI

P

OR, 95% CI

P

Continuous variable

12,966

75.95

77.90

74.60

1.10 (1.07, 1.13)

<0.001

1.06 (1.02, 1.10)

0.002

Quartiles

 Q1 (<4.4)

3201

73.38

76.73

72.75

1

 

1

 

 Q2 (4.4–5.3)

3248

74.26

75.95

73.51

1.05 (0.936, 1.17)

0.423

1.00 (0.891, 1.13)

0.982

 Q3 (5.3–6.4)

3259

76.65

77.22

76.15

1.19 (1.06, 1.33)

0.002

1.12 (0.988, 1.27)

0.076

 Q4 (≥6.5)

3258

79.47

79.62

79.16

1.40 (1.25, 1.58)

<0.001

1.21 (1.05, 1.40)

0.008

Binary Classification

 Non-hyperuricemia

10,007

74.97

77.00

73.60

1

 

1

 

 Hyperuricemia

2959

79.48

80.40

78.50

1.28 (1.16, 1.42)

<0.001

1.18 (1.05, 1.33)

0.004

  1. Non-hyperuricemia SUA < 7.0 mg/dl in males and SUA < 6.0 mg/dl in females, hyperuricemia SUA ≥7.0 mg/dl in males and SUA ≥6.0 mg/dl in females
  2. Binary logistic regression models evaluating the association of serum uric acid (SUA) with hypertensive retinopathy (HR). CI confidence interval OR odds ratio
  3. Model 1: unadjusted
  4. Model 2: adjusted for age, sex, study center, treatment group, body mass index(BMI), SBP, DBP, creatinine, triglycerides, and fasting plasma glucose if not stratified
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us